Skip to main content
SpringerLink
Log in

Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition in Obese Females with Type 2 Diabetes Mellitus: Results After 1-Year Follow-up

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Purpose

To present the early metabolic effects of sleeve gastrectomy with transit bipartition (SG + TB) procedure in female obese patients with type 2 diabetes mellitus (T2DM).

Methods

This prospective clinical study was carried out between January 2016 and June 2017. Inclusion criteria were female participants under 60 years old with T2DM, body mass index ≥ 40 kg/m2 and HbA1c level ≥ 8%. All patients underwent to SG + TB procedure. Primary outcomes were the glycemic control variables, and the secondary outcomes were weight loss and dyslipidemia levels up to the last follow-up point.

Results

A total of 35 female participants with an average age of 48.8 ± 6.0 years old and a mean preoperative BMI of 42.0 ± 1.3 kg/m2 were included during the study period. Diabetic remission was achieved in 88.6% of patients (n = 31) on the third month without any antidiabetic medications. The mean postoperative BMI of patients was 24.8 ± 1.6 kg/m2, and dyslipidemia levels were significiantly lower at the last follow-up point of all patients.

Conclusions

SG + TB procedure may be a potent therapeutic option for the treatment of obese patients with T2DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555–63.

    Article  CAS  PubMed  Google Scholar 

  2. Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(Suppl.1):53–61.

    Article  Google Scholar 

  3. Bays HE, Chapman R, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61:737–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia. 2002;45:S23–8.

    Article  CAS  PubMed  Google Scholar 

  5. Rubino F, Kaplan LM, Schauer PR, et al. The diabetes surgery summit consensus conference. Ann Surg. 2010;251(3):399–405.

  6. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

  7. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial Roux-en-Y gastric bypass and diabetes. JAMA. 2013;309(21):2240–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.

    Article  PubMed  Google Scholar 

  9. Rubino F, Nathan D, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12:1144–62.

  10. Cohen RV, Shikora S, Petry T, et al. The diabetes surgery summit II guidelines: a disease-based clinical recommendation. Obes Surg. 2016;26(8):1989–9.

  11. Santoro S. From bariatric to pure metabolic surgery: new concepts on the rise. Ann Surg. 2015;262:79–80.

    Article  Google Scholar 

  12. Arslan E, Sipahi M, Banli O. Early results of laparoscopic sleeve gastrectomy with loop bipartition. Surg Laparosc Endosc Percutan Tech. 2018; https://doi.org/10.1097/SLE.0000000000000541.

  13. Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018;28(1):77–86.

    Article  PubMed  Google Scholar 

  14. Celik A, Ugale S, Ofluoglu H, et al. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25(7):1184–90.

    Article  PubMed  Google Scholar 

  15. Yan Y, Sha Y, Yao G, et al. Roux-en-Y gastric bypass versus medical treatment for type 2 diabetes mellitus in obese patients: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(17):e3462.

    Article  CAS  Google Scholar 

  16. Members of the expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care.

  17. Santoro S, Castro LC, Velhote MCP, et al. Sleeve gastrectomy with transit bipartition. A potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256(1):104–10.

    Article  PubMed  Google Scholar 

  18. American Diabetes Association. Data from the National Diabetes Statistics Report, 2014. Available at: http://www.diabetes.org/diabetes-basics/statistics/. Accessed June 10, 2014.

  19. Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.

  20. Dixon JB, Zimmet P, Alberti KG, et al. International diabetes federation taskforce on epidemiology and prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes [review]. Arq Bras Endocrinol Metabol. 2011;55(6):367–82.

  21. Mingrone G, Nolfe G, Gissey GC, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52(5):873–81.

    Article  CAS  PubMed  Google Scholar 

  22. Griffo E, Cotugno M, Nosso G, et al. Effects of sleeve gastrectomy and gastric bypass on postprandial lipid profile in obese type 2diabetic patients: a 2-year follow-up. Obes Surg. 2016;26(6):1247–5.

    Article  CAS  PubMed  Google Scholar 

  23. Azevedo FR, Santoro S, Correa-Giannella ML, et al. A prospective randomized controlled trial of the metabolic effects of sleeve gastrectomy with transit bipartition. Obes Surg. 2018 Apr 27;28:3012–9. https://doi.org/10.1007/s11695-018-3239-3.

    Article  PubMed  Google Scholar 

  24. Jørgensen NB, Dirksen C, Bojsen-Møller KN, et al. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations. J Clin Endocrinol Metab. 2015;100(3):E396–406.

    Article  CAS  PubMed  Google Scholar 

  25. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  CAS  PubMed  Google Scholar 

  26. Lebel S, Dion G, Marceau S, et al. Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial. Surg Obes Relat Dis. 2016;12(5):1014–20.

    Article  PubMed  Google Scholar 

  27. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89. https://doi.org/10.1007/s11695-017-2666-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. H B, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.

    Article  Google Scholar 

  29. Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.

    Article  PubMed  Google Scholar 

  30. Leonetti F, Capoccia D, Coccia F, et al. Obesity, type 2 diabetes mellitus, and other comorbidities: a prospective cohort study of laparoscopic sleeve gastrectomy vs medical treatment. Arch Surg. 2012;147(8):694–700.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The author would like to thank Faruk Karateke, MD for his critical review of the paper.

Author information

Authors and Affiliations

  1. Department of General Surgery, VM Medical Park Mersin Hospital, Mersin, Turkey

    Tuna Bilecik

Authors
  1. Tuna Bilecik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tuna Bilecik.

Ethics declarations

Conflict of Interest

The author declares that he has no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilecik, T. Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition in Obese Females with Type 2 Diabetes Mellitus: Results After 1-Year Follow-up. OBES SURG 29, 805–810 (2019). https://doi.org/10.1007/s11695-018-3603-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-3603-3

Keywords

Search

Navigation